The monitoring of vancomycin: a systematic review and meta-analyses of area under the concentration-time curve-guided dosing and trough-guided dosing
M Tsutsuura, H Moriyama, N Kojima, Y Mizukami… - BMC infectious …, 2021 - Springer
Background This systematic review and meta-analysis explored the relationship between
vancomycin (VCM) monitoring strategies and VCM effectiveness and safety. Methods We …
vancomycin (VCM) monitoring strategies and VCM effectiveness and safety. Methods We …
Risk factors for vancomycin‐associated acute kidney injury: A systematic review and meta‐analysis
JY Kim, J Yee, HY Yoon, JM Han… - British Journal of …, 2022 - Wiley Online Library
Aims This systematic literature review and meta‐analysis aimed to evaluate the risk factors
for vancomycin‐associated acute kidney injury (AKI) incidence. Methods This study …
for vancomycin‐associated acute kidney injury (AKI) incidence. Methods This study …
Vancomycin area under the curve–guided dosing and monitoring for adult and pediatric patients with suspected or documented serious methicillin-resistant …
TP Lodise, G Drusano - Clinical Infectious Diseases, 2021 - academic.oup.com
The revised vancomycin consensus guidelines recommended area under the curve (AUC)–
guided dosing/monitoring for patients with serious invasive methicillin-resistant …
guided dosing/monitoring for patients with serious invasive methicillin-resistant …
Optimal practice for vancomycin therapeutic drug monitoring: position statement from the anti-infectives committee of the international association of therapeutic drug …
Individualization of vancomycin dosing based on therapeutic drug monitoring (TDM) data is
known to improve patient outcomes compared with fixed or empirical dosing strategies …
known to improve patient outcomes compared with fixed or empirical dosing strategies …
Vancomycin advanced therapeutic drug monitoring: exercise in futility or virtuous endeavor to improve drug efficacy and safety?
Vancomycin is commonly prescribed to hospitalized patients. Decades of pharmacokinetic/
pharmacodynamic research culminated in recommendations to monitor the ratio of the area …
pharmacodynamic research culminated in recommendations to monitor the ratio of the area …
Area-Under-Curve–Guided Versus Trough-Guided Monitoring of Vancomycin and Its Impact on Nephrotoxicity: A Systematic Review and Meta-Analysis
AS Lim, SHW Foo, JJB Seng, TTM Ng… - Therapeutic Drug …, 2023 - journals.lww.com
Background: Conventionally, vancomycin trough levels have been used for therapeutic drug
monitoring (TDM). Owing to the increasing evidence of trough levels being poor surrogates …
monitoring (TDM). Owing to the increasing evidence of trough levels being poor surrogates …
Safety and effectiveness of fifth generation cephalosporins for the treatment of methicillin-resistant staphylococcus aureus bloodstream infections: a narrative review …
DF Bavaro, A Belati, L Bussini, V Cento… - Expert Opinion on …, 2024 - Taylor & Francis
ABSTRACT Introduction Methicillin-resistant Staphylococcus aureus (MRSA) bloodstream
infection (BSI) is a major issue in healthcare, since it is often associated with endocarditis or …
infection (BSI) is a major issue in healthcare, since it is often associated with endocarditis or …
Comparison of single trough-based area under the concentration–time curve versus trough concentration for the incidence of vancomycin-associated nephrotoxicity
T Niwa, M Yasue, S Harada, Y Yamada… - Journal of Infection and …, 2022 - Elsevier
Introduction While the revised 2020 consensus guideline recommends the use of area
under the concentration–time curve (AUC)-guided vancomycin monitoring, collecting …
under the concentration–time curve (AUC)-guided vancomycin monitoring, collecting …
[HTML][HTML] Evaluation of vancomycin TDM strategies: prediction and prevention of kidney injuries based on vancomycin TDM results
The current guidelines for therapeutic drug monitoring (TDM) of vancomycin suggest a target
24-hour area under the curve (AUC 0-24) of 400 to 600 mg* h/L for serious methicillin …
24-hour area under the curve (AUC 0-24) of 400 to 600 mg* h/L for serious methicillin …
A Canadian perspective on the revised 2020 ASHP–IDSA–PIDS–SIDP guidelines for vancomycin AUC-based therapeutic drug monitoring for serious MRSA …
JJ Stewart, SCJ Jorgensen, L Dresser… - Official Journal of …, 2021 - jammi.utpjournals.press
Background: A revised consensus guideline on therapeutic drug monitoring (TDM) of
vancomycin for serious methicillin-resistant Staphylococcus aureus (MRSA) infections was …
vancomycin for serious methicillin-resistant Staphylococcus aureus (MRSA) infections was …